Covered recipient · General Payments record
ROBERT S NAYLOR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$268.38
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $201.98 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $60.27 | 3 |
| PFIZER INC. | $59.45 | 3 |
| GlaxoSmithKline, LLC. | $35.54 | 2 |
| Acerta Pharma LLC | $27.93 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105686115 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.54 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105631899 | CMS |
| GlaxoSmithKline, LLC. | $17.81 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116531918 | CMS |
| GlaxoSmithKline, LLC. | $17.73 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115746580 | CMS |
| Lilly USA, LLC | $16.36 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135399325 | CMS |
| Lilly USA, LLC | $17.80 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373900 | CMS |
| Lilly USA, LLC | $26.11 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135361802 | CMS |
| Novartis Pharmaceuticals Corporation | $18.79 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087156036 | CMS |
| PFIZER INC. | $17.50 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164155 | CMS |
| PFIZER INC. | $21.41 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131523686 | CMS |
| PFIZER INC. | $20.54 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131877552 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.